Myelodysplastic syndrome terminating in erythropoietic protoporphyria after 15 years of aplastic anemia

International Journal of Hematology

Volumn 72, Issue 1, 2000, Pages 44-47

  Shirota, Tsunemichi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Aplastic anemia; Erythropoietic protoporphyria; Myelodysplastic syndrome

Indexed keywords

PORPHYRIN;

APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CASE REPORT; FATALITY; FEMALE; HEPATOERYTHROPOIETIC PORPHYRIA; HUMAN; JAPAN; KARYOTYPING; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PATHOLOGY; REFRACTORY ANEMIA; URINE;

ANEMIA, APLASTIC; ANEMIA, REFRACTORY; BONE MARROW CELLS; FATAL OUTCOME; FEMALE; HUMANS; JAPAN; KARYOTYPING; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PORPHYRIA, HEPATOERYTHROPOIETIC; PORPHYRINS;

EID: 0034219372     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Sassa S. Hematologic aspects of the porphyrias. Int J Hematol. 2000;71:1-17.
2. Sassa S. Recent progress in heme synthesis and metabolism. In: Fujita H, ed. Regulation of Heme Protein Synthesis. New York: Alpha Med Press; 1994:1-10.
3. Kappas A, Sassa S, Galbraith R A, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill; 1995:2103-2159.
4. El-Sharabasy MMH, El-Waseef AM, Hafez MM, Salim SA. Porphyrin metabolism in some malignant diseases. Brit J Cancer. 1992; 65:409-412.